-
IntroducedJul 21, 2026
-
Passed Senate
-
Passed House
-
Became Law
United States Senate Bill
A bill to direct the Food and Drug Administration to prevent the importation of counterfeit, unapproved, misbranded, or adulterated drugs from the People's Republic of China or other foreign countries, to establish enhanced safeguards for imported drug products, and for other purposes.
Last Action See all actions
Senate • Jul 21, 2026: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Summary
Comments on S 5043
Tweets
Whip Lists
Sponsors
Votes
Actions
- Jul 21, 2026 | Senate
- Introduced in Senate
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill Texts
Documents
